PBGH Announcements

For Media Inquiries:

Lisa Zamosky
(917) 751-0232

March 16, 2020

PBGH Announces Shawn Gremminger as Director, Health Policy

Pacific Business Group on Health (PBGH) is pleased to announce Shawn Gremminger as Director, Health Policy beginning on March 16, 2020.

February 24, 2020

Employers Support Bipartisan Bill to Increase Drug Price Transparency and Reduce Gaming by Middlemen

Employers’ Prescription for Affordable Drugs (EmployersRx) has announced its support of H.R. 5304, the “PBM Transparency and Prescription Drug Costs Act.” This bipartisan legislation will markedly lower private health insurance premiums and increase competition in the marketplace, according to a July 2019 report from the Congressional Budget Office.

February 7, 2020

Statement of Record for House Committee on Ways and Means, Subcommittee on Health

Chairman Doggett, Ranking Member Nunes, and members of the House Ways and Means Health Subcommittee, thank you for the opportunity to provide a written statement for today’s hearing on behalf of the Employers’ Prescription for Affordable Drugs (EmployersRx), a coalition of employers united in advocacy to drive down the cost of prescription drugs—one of the biggest challenges in health care.

February 4, 2020

No More ‘Sucker at the Table’: New Coalition to Represent Fortune 500 Firms Paying Prescription Drug Bills

Tired of being “the sucker at the table,” a group representing Fortune 500 companies has formed a lobby to push congressional drug-pricing policies that focus beyond Medicare. Employers’ Prescription for Affordable Drugs has described its goal as “to mobilize large employers to drive down prescription drug costs by advocating for public policies based on increased competition, transparency and value.”

February 3, 2020

Employers Shoulder Plenty of Drug Costs, but Haven’t Lobbied Much to Lower Them — Until Now

Legislation aiming to reduce drug prices has thus far focused on changes to federal programs such as Medicare. But Walmart, Pepsi, and other large companies provide employer-sponsored health insurance to more than 150 million Americans, making them the largest footers of health bills.

January 21, 2020

Coalition Advocates for Biosimilar Uptake to Help Lower Employers’ Drug Cost Burden

Rising drug costs in the United States are a pressing concern not only for patients who need to receive those drugs, but also for employers. The Employers’ Prescription for Affordable Drugs (EmployersRx) is a coalition that aims to tackle this problem by working with policy makers and stakeholders to encourage and facilitate more transparency, competition, and value in the healthcare system.

January 6, 2019

Lisa Zamosky joins PBGH as Chief Communications Officer

Lisa Zamosky joins PBGH on January 20, 2020 as Chief Communications Officer. Lisa brings extensive communications and healthcare expertise to PBGH, where she will help accelerate PBGH’s vision of improving health outcomes, experience, and affordability for consumers and purchasers.

January 6, 2019

PBGH issues statement on Sutter Health settlement

Read the statement issued by PBGH CEO Elizabeth Mitchell on the settlement of the lawsuit against Sutter Health System regarding alleged consolidation practices.

January 6, 2019

Susan Au, CPA, MBA joins PBGH as Chief Financial Officer

Susan Au, CPA, MBA joins PBGH on January 27, 2020 as Chief Financial Officer.

January 6, 2019

PBGH launches EmployersRx

PBGH has launched the Employers’ Prescription for Affordable Drugs (EmployersRx), a coalition uniting employers in advocacy for policies that will address our nation’s biggest health care challenge—the high cost of prescription drugs.